Table 2.
Etiology of Infection and Antimicrobial Susceptibility Pattern of ESBL-Producing Enterobacterales Isolates
| Etiology | n = 153 (%) |
|---|---|
| Escherichia coli | 74 (48.3) |
| Klebsiella pneumoniae | 45 (29.4) |
| Enterobacter spp. | 22 (14.4) |
| Serratia marcescens | 5 (3.3) |
| Proteus spp. | 3 (2) |
| Citrobacter spp. | 2 (1.3) |
| Morganella morganii | 2 (1.3) |
| Antimicrobial Agent | No. of Susceptible Strains (%) |
| Amikacin | 128 (83.6) |
| Ceftolozane/tazobactam | 153 (100) |
| Ciprofloxacin | 74 (48.3) |
| Colistin | 145 (94.7) |
| Gentamicin | 119 (77.7) |
| Fosfomycin | 132 (86.2) |
| Levofloxacin | 88 (57.5) |
| Meropenem | 153 (100) |
| Piperacillin/tazobactam | 104 (67.9) |
| Imipenem/cilastatin | 153 (100) |
Abbreviation: ESBL, extended-spectrum β-lactamase.